OBJECTIVE: To assess the impact and the subjective benefit of Bone-anchored Hearing Aid (BAHA) implementation in patients with hearing impairment combined with moderate mental retardation. STUDY DESIGN: Case control study using two validated patient-oriented instruments. SETTING: Tertiary referral center. PATIENTS: Twenty-two patients with moderate mental retardation and conductive or mixed hearing loss. INTERVENTION: Rehabilitative. MAIN OUTCOME MEASURES: Subjective benefit, listening and learning capabilities. RESULTS: BAHA implementation in patients with moderate mental retardation, by using the Glasgow Children's Benefit Inventory and the Listening Inventory for Education, showed a subjective benefit, which was comparable with that of the control group and was consistent with the results of earlier studies. CONCLUSION: The use of BAHA proved beneficial in most patients with hearing impairment and moderate mental retardation. Extending the indications for BAHA application to this special patient group shows to be a very valuable option.
OBJECTIVE: To assess the impact and the subjective benefit of Bone-anchored Hearing Aid (BAHA) implementation in patients with hearing impairment combined with moderate mental retardation. STUDY DESIGN: Case control study using two validated patient-oriented instruments. SETTING: Tertiary referral center. PATIENTS: Twenty-two patients with moderate mental retardation and conductive or mixed hearing loss. INTERVENTION: Rehabilitative. MAIN OUTCOME MEASURES: Subjective benefit, listening and learning capabilities. RESULTS: BAHA implementation in patients with moderate mental retardation, by using the Glasgow Children's Benefit Inventory and the Listening Inventory for Education, showed a subjective benefit, which was comparable with that of the control group and was consistent with the results of earlier studies. CONCLUSION: The use of BAHA proved beneficial in most patients with hearing impairment and moderate mental retardation. Extending the indications for BAHA application to this special patient group shows to be a very valuable option.
Authors: G Ricci; A Della Volpe; M Faralli; F Longari; M Gullà; N Mansi; A Frenguelli Journal: Eur Arch Otorhinolaryngol Date: 2010-06-10 Impact factor: 2.503
Authors: Hubert T Faber; Maarten J F de Wolf; Cor W R J Cremers; Ad F M Snik; Myrthe K S Hol Journal: Eur Arch Otorhinolaryngol Date: 2012-08-19 Impact factor: 2.503
Authors: Theresa Y S Leow; Stijn Bekkers; Arno M Janssen; Sjoert A H Pegge; Henricus P M Kunst; Jerome J Waterval; Thijs T G Jansen; Stefanie S V Henriet; Koen J van Aerde; Jakko van Ingen; Myrthe K S Hol Journal: Clin Otolaryngol Date: 2022-03-30 Impact factor: 2.729